Twitxy Saved

Jothydev Kesavadev

Verified account This account is verified. Learn more

@jothydev

A physician, researcher,social worker committed to diabetes care and research.
Trivandrum, Kerala, India jothydev.net Joined August 2009
100 Following 1.1K Followers 916 Posts

Latest posts 5

Jothydev Kesavadev Verified account @jothydev
Press Trust of India Verified account @PTI_News 3d
VIDEO | Thiruvananthapuram: Early diabetes screening from age 20 crucial to prevent complications, says Diabetologist Dr. Jothydev Kesavadev.

On the occasion of World Diabetes Day, Diabetologist & Founder of Jothydev's Diabetes Research Center Dr. Jothydev Kesavadev stresses (@jothydev) the importance of early diabetes screening, recommending testing from the age of 20. He warns that diabetes often goes undetected for 6–10 years due to the absence of early symptoms.

He highlights the role of AI-powered tools and modern treatments in early diagnosis and managing complications. He also urges people to monitor abdominal obesity, noting that a waist circumference above 80 cm in women and 90 cm in men may indicate increased health risks.

#WorldDiabetesDay #EarlyDiabetesDetection #DiabetesAwareness #DiabetesPrevention #HealthyLifestyle

(Full video available on PTI Videos - ptivideos.com)
View quoted post on X
Jothydev Kesavadev Verified account @jothydev
A MILESTONE FOR DIABETES TECHNOLOGY IN INDIA! 🇮🇳

The RSSDI Consensus Statement on the Use of Diabetes Technology in India has now been published in the International Journal of Diabetes in Developing Countries, the official journal of RSSDI, published by Springer Nature.

This landmark consensus represents an important step towards making diabetes technologies more accessible, evidence-based, and relevant to Indian clinical practice.

My sincere gratitude to Dr.Anuj Maheshwari, National President of RSSDI, who entrusted me with the responsibility of leading this initiative.

I am equally grateful to Dr.Rakesh Parikh, Secretary General of RSSDI, and the entire RSSDI Central Executive Committee for their wholehearted support.

What makes this consensus particularly special is the extraordinary nationwide collaboration, bringing together an exceptionally broad representation of India’s leading diabetes technology experts actively involved in clinical practice and research.

Special appreciation to Anjana Basanth and the dedicated team at Jothydev’s Diabetes Research Centre (JDC) for coordinating the consensus surveys, the development process, and the extensive medical writing.

KEY HIGHLIGHTS OF THE CONSENSUS

🔹 45 consensus statements across 8 domains, addressing the practical application of diabetes technologies in India.

🔹 SMBG: Structured monitoring linked to actionable therapeutic decisions.

🔹 CGM: Expanding access, standardizing interpretation, and integrating CGM into routine care.

🔹 Automated Insulin Delivery (AID): Facilitating early access to advanced insulin delivery, particularly in type 1 diabetes.

🔹 Telemedicine & Digital Health: Strengthening remote monitoring and continuity of care.

🔹 AI & Wearables: Promoting clinically validated innovations while cautioning against unproven technologies.

🔹 Education & Safety: Emphasizing patient education, professional training, and technical support.

🔹 Affordability & Equity: Advocating wider access through resource-adapted approaches and healthcare support.

The recommendations were developed through a structured two-round modified Delphi process, achieving consensus across all 45 statements.

The official release will take place at the 54th RSSDI Annual Conference, Bengaluru, 19–22 November 2026.

My heartfelt appreciation to every member of the Diabetes Technology Consensus Group for their invaluable contributions.

Technology should not remain a privilege available to a few. Our collective mission is to make evidence-based diabetes technologies accessible to everyone who can benefit from them.

#RSSDI #DiabetesTechnology #CGM #AutomatedInsulinDelivery #DigitalHealth #DiabetesCare #JothydevKesavadev
Jothydev Kesavadev Verified account @jothydev
Vaccines are not just for children. They are an essential part of preventive medicine throughout adulthood and particularly important for people living with diabetes.

Had the privilege of speaking on vaccination at the 14th Ahuja Bajaj Symposium, organised by Padma Shri Dr.Anoop Misra and his outstanding team in New Delhi.
@docanoopmisra
An important question I addressed was: Which vaccines are essential for people with diabetes, and which vaccines should otherwise healthy individuals receive as they grow older?

People with diabetes are at increased risk of certain infections and their complications. Yet, vaccination remains an underutilised component of comprehensive diabetes care.

I highlighted several important vaccines and the need to integrate vaccination into routine clinical practice:

🔹 Annual influenza vaccination-an important preventive measure for people with diabetes and older adults.

🔹 Pneumococcal conjugate vaccine (Prevenar 20), to help protect against pneumococcal disease, including serious infections such as pneumonia.

🔹 Recombinant zoster vaccine (Shingrix), to prevent herpes zoster (shingles) and its complications, particularly in older adults.

🔹 Dengue vaccination (Qdenga), an important new development for India following its approval in July 2026. Appropriate patient selection, contraindications and the recommended two-dose schedule must guide its use.

Beyond diabetes, vaccination needs to be considered across the adult lifespan, based on age, previous immunisation, comorbidities and individual risk. Vaccines against influenza, pneumococcal disease, herpes zoster, tetanus, diphtheria and pertussis, hepatitis B, and other vaccine-preventable infections deserve appropriate attention.

I also revisited two important contributions to this field: our 2012 publication, “Suggested Use of Vaccines in Diabetes,” and the 2024 RSSDI update on vaccination in people with diabetes, co-authored with Dr Sanjay Agarwal and Dr. Banshi Saboo.

These publications reflect a continuing effort to translate scientific evidence into practical recommendations for Indian clinical practice.

My message to healthcare professionals is simple: vaccination should be discussed proactively, not left until an infection occurs. Just as we routinely assess glucose, blood pressure, lipids, kidney function and cardiovascular risk, we should also review each patient’s vaccination status.

Preventing an infection is often better than treating its complications.

My sincere thanks to Dr. Anoop Misra and the entire organising team for providing an excellent platform for scientific discussion.

#Diabetes #Vaccination #PreventiveMedicine #Influenza #PneumococcalVaccine #Shingrix #Qdenga #PublicHealth #RSSDI #AhujaBajajSymposium
Jothydev Kesavadev Verified account @jothydev
“A normal BMI does not necessarily mean you are metabolically healthy.”

Delighted to share my recent interview with The New Indian Express, in conversation with the journalist, Unnikrishnan S, on some of the often-overlooked warning signs of metabolic dysfunction, insulin resistance, obesity and diabetes.

One of the most important messages is that fasting blood glucose alone may not tell the whole story. Metabolic dysfunction can begin well before diabetes is diagnosed, and apparently healthy individuals may already have underlying risks.

In this interview, I discussed several important issues:

🔹 Post-meal glucose spikes: Why glucose levels may rise abnormally after meals even when fasting values appear reassuring, and how continuous glucose monitoring (CGM) can help identify these patterns.

🔹 Normal BMI, but hidden metabolic risk: Why waist circumference, waist-to-height ratio and visceral fat deserve attention, even in individuals who are not visibly overweight.

🔹 Sleep, stress and sedentary behaviour: Why sleep deprivation, prolonged sitting and irregular routines can adversely affect metabolic health.

🔹 Late-night eating: How meal timing, circadian rhythms and individual differences in glucose responses influence metabolic outcomes.

🔹 Crash diets and weight management: Why extreme dietary restriction may backfire, and why sustainable lifestyle interventions, alongside evidence-based anti-obesity medications when indicated, can be important for appropriate patients.

My message is simple: Do not wait for blood glucose to become abnormal before paying attention to metabolic health.

Early identification of insulin resistance, abdominal obesity and fatty liver disease, followed by appropriate lifestyle interventions and timely medical management, offers an opportunity to reduce future risks.

We need to move beyond looking at body weight or a single laboratory value in isolation and adopt a more comprehensive, personalised approach to metabolic health.

My sincere thanks to journalists, Anil S, Unnikrishnan, The New Indian Express, for bringing these important health messages to a wider audience.

#MetabolicHealth #DiabetesPrevention #InsulinResistance #Obesity #CGM #FattyLiver #PreventiveHealthcare #TheNewIndianExpress
Jothydev Kesavadev Verified account @jothydev
BYD SEALION 7 OWNERS: IS THIS NORMAL?

PREMIUM TECHNOLOGY, BUT TERRIBLE SIDE-TO-SIDE ROCKING! (Body roll)

We purchased our BYD Sealion 7 on 29 July 2025, with enormous excitement and confidence in BYD’s technology. @jkrishnadev @SJothydev66063

Having owned Mercedes-Benz and Volvo vehicles, my son and I chose BYD because of our passion for innovation, electric mobility, and its revolutionary Blade Battery technology. @BYDCompany @BYDGlobal

There is much we genuinely admire about this vehicle.

But today, we are deeply concerned about our family’s comfort and safety.

Our Sealion 7 has developed disturbing side-to-side rocking, even over minor road irregularities and small bumps.

At times, it feels as though an external force is suddenly pushing the vehicle sideways!

The consequences are distressing:

• Our one-year-old granddaughter experiences repeated sideways jolts in her car seat.

• Elderly family members suffer significant neck and back discomfort.

• Passengers in both front and rear seats experience sudden lateral movements.

Interestingly, we do not remember experiencing anything remotely similar during the initial months of ownership.

The problem became noticeable around the period following our first service on 10 April 2026. We are not suggesting that the service caused it, but this is the timeline we experienced.

Despite multiple telephone conversations with BYD representatives and assurances of a callback, we are still awaiting a satisfactory technical explanation.

I have also come across published automotive reviews mentioning side-to-side movement and ride-comfort concerns with the Sealion 7.

SO, MY QUESTIONS TO BYD AND FELLOW SEALION 7 OWNERS ARE:

Is this normal behaviour for the Sealion 7? Or is there something seriously wrong with our particular vehicle?

If BYD considers this normal, we would appreciate a clear technical explanation.

We genuinely love technology. That is precisely why we invested in BYD.

But technological innovation should never come at the expense of passenger comfort and safety.

I request BYD India to urgently investigate our vehicle, conduct a comparative road test, and provide a written technical assessment.

Fellow BYD Sealion 7 owners, PLEASE SHARE YOUR EXPERIENCES. Have you noticed similar side-to-side rocking?

🎥 The accompanying video shows my son driving and the disturbing lateral movements we are experiencing.

#BYD #BYDSealion7 #BYDIndia #ElectricVehicles #VehicleSafety #ConsumerSafety
0:38